Abstract: Background and objective: The purpose of this
study was to assess the efficacy of SAPS II scoring in predicting mortality and
morbidity in patients with perforated peritonitis. To supply patients with
perforation peritonitis with an objective prognostic method. For the purpose of
providing a risk classification system for patients with perforation
peritonitis.
Method: The participants in a prospective observational
study included 125 adults over the age of 18 who presented to the surgical ward
at Department of General Surgery, Dhanalakshmi Srinivasan Medical College &
Hospital, Perambalur, Tamil Nadu, India. with symptoms of perforation
peritonitis from June 2018 to May 2019. These symptoms included abdominal
tenderness, guarding, rigidity, and rebound tenderness. Additionally, the
participants' x-rays showed air under the diaphragm.
Result: 125 patients who were admitted to our
hospital during the study period all had their SAPS II scores calculated. There
were 102 males and 23 females total. Those with a SAPS II score below 20 may be
categorized separately from those with a score between 21 and 40, while those
with a score over 40 could be categorized separately from those with a score
between 21 and 80. The low-risk category included those with a SAPS II score of
less than 20, who experienced no deaths and required shorter hospital stays.
Patients with a SAPS II score between 21 and 40 were considered to be in the
moderate risk group; those with a score of 40 or higher had the highest
mortality rate.
Conclusion: The severity of a patient's perforation
peritonitis can be predicted with high accuracy using the Sequential Organ Failure
Assessment (SAPS) II score.
